Efficacy of guselkumab compared with adalimumab for psoriasis: a meta-analysis of randomized controlled studies

INTRODUCTION: The efficacy of guselkumab versus adalimumab for psoriasis remains controversial. AIM: We conducted a systematic review and meta-analysis to explore the influence of guselkumab versus adalimumab on treatment efficacy for psoriasis. MATERIAL AND METHODS: We have searched PubMed, Embase,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Hongyi, Guo, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704462/
https://www.ncbi.nlm.nih.gov/pubmed/36457680
http://dx.doi.org/10.5114/ada.2022.120886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704462/
https://www.ncbi.nlm.nih.gov/pubmed/36457680
http://dx.doi.org/10.5114/ada.2022.120886

Ejemplares similares